Skip to main content

Advertisement

SpringerLink
Log in

Antitumor Effects of JAK3 Inhibitor on the Model of Transplantable Lewis Lung Carcinoma and Mechanisms of Their Development

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Mice with Lewis lung carcinoma were used to study the antitumor and antimetastatic effects of JAK3 inhibitor. The study revealed no effect of JAK3 inhibitor on the growth of primary tumor node, but found a pronounced inhibition of hematogenous spread of the pathologic process into the lungs. In vitro blockade of JAK3 in cultured Lewis lung carcinoma produced no effect on the count of the stem tumor cells and stimulated functions of committed elements. In addition, blockade of JAK3 significantly elevated maturation index of the tumor tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nemtsova MV, Kushlinskii NE. Tumor clonality: research and clinical aspects. Bull Exp Biol Med. 2014;158(2):246-51.

    Article  CAS  PubMed  Google Scholar 

  2. Novik AA, Kamilova TA, Tsugan VN. Introduction in Molecular Biology of Cancerogenesis. Moscow, 2004. Russian.

  3. Guidelines in Chemotherapy of Tumor Diseases. Perevodchikov NI, Gorbunov VA, eds. Moscow, 2015. Russian.

  4. Rybalkina OYu, Razina TG, Lopatina KA, Amosova EN, Krylova SG, Efimova LA, Safonova EA, Zueva EP, Khotimchenko MYu, Khotimchenko YuS. Effects of nonstarch polysaccharides with different molecular weights on the development of Lewis lung carcinoma in mice and efficiency of cytostatic therapy. Bull. Exp. Biol. Med. 2013;154(4):492-496.

  5. Treshchalina EM, Zhukova OS, Gerasimova GK, Andronova NV, Garin AM. Methodical Recommendations on Studying the Antitumor Activity of Pharmaceuticals. Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2013. pp. 621-657. Russian.

  6. Chissov VI, Sergeeva NS, Sviridova IK, Pelevina II. The stem (clonogenic) cells of cancer: returning to the earlier received data. Ross. Bioter. Zh. 2006;5(2):7-12. Russian.

  7. Abdelraouf F, Smit E, Hasan B, Menis J, Popat S, van Meer-beeck JP, Surmont VF, Baas P, O’Brien M. Sunitinib (SU11248) in patients with chemo naive mall cell lung cancer or who have a “chemosensitive” relapse: A single-arm phase II study (EORTC-08061). Eur. J. Cancer. 2015; 54:35-39.

    Article  PubMed  Google Scholar 

  8. Dygai AM, Zyuz’kov GN, Zhdanov VV, Udut EV, Miroshnichenko LA, Khrichkova TY, Simanina EV, Stavrova LA, Chaikovskiy AV, Markova TS, Minakova MY, Gol’dberg VE, Artamonov AV, Bekarev AA, Madonov PG, Kinsht DN, Gurto RV. Effect of Hyaluronidase immobilized using electron-beam synthesis nanotechnology on sensitivity of progenitor cells to regulatory factors. Bull. Exp. Biol. Med. 2011;151(1):150-153.

    Article  CAS  PubMed  Google Scholar 

  9. Leonard WJ, O’Shea JJ. JAKs and STATs: biological implications. Annu. Rev. Immunol. 1998;16:293-322.

    Article  CAS  PubMed  Google Scholar 

  10. Pemmaraju N, Mesa R. Evidence for Janus kinase (JAK) inhibitors for the prevention of major morbid events in patients with myeloproliferative neoplasms (MPNs). Hematology Am. Soc. Hematol. Educ. Program. 2015;2015(1):649-651. doi: 10.1182/asheducation-2015.1.649.

    PubMed  Google Scholar 

  11. Schönberg K, Rudolph J, Vonnahme M, Parampalli Yajnanarayana S, Cornez I, Hejazi M, Manser AR, Uhrberg M, Verbeek W, Koschmieder S, Brümmendorf TH, Brossart P, Heine A, Wolf D. JAK inhibition impairs NK cell function in myeloproliferative neoplasms. Cancer Res. 2015;75(11):2187-2199.

    Article  PubMed  Google Scholar 

  12. Wu J, Liu S, Fan Z, Zhang L, Tian Y, Yang R. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice. Tumour Biol. 2016 Jan 5. [Epub ahead of print].

  13. Yokoyama S, Perera PY, Terawaki S, Watanabe N, Kaminuma O, Waldmann TA, Hiroi T, Perera LP. Janus Kinase inhibitor tofacitinib shows potent efficacy in a mouse model of autoimmune lymphoproliferative syndrome (ALPS). J. Clin. Immunol. 2015;35(7):661-667.

    Article  CAS  PubMed  Google Scholar 

  14. Zyuz’kov GN, Krapivin AV, Nesterova YV, Povetieva TN, Zhdanov VV, Suslov NI, Fomina TI, Udut EV, Miroshnichenko LA, Simanina EV, Semenov AA, Kravtsova SS, Dygai AM. Mechanisms of Regeneratory Effects of Baikal Aconite Diterpene Alkaloids. Bull. Exp. Biol. Med. 2012;153(6):846-850.

    PubMed  Google Scholar 

  15. Zyuz’kov GN, Zhdanov VV, Udut EV, Miroshnichenko LA, Danilets MG, Simanina EV, Trofimova ES, Chaikovskii AV, Agafonov VI, Sherstoboev EY, Minakova MY, Burmina YV, Udut VV, Dygai AM. Role of JNK and contribution of p53 into growth potential of mesenchymal progenitor cells in vitro. Bull. Exp. Biol. Med. 2015;159(2):245-247.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia

    G. N. Zyuz’kov, E. N. Amosova, A. V. Chaikovskii, L. A. Miroshnichenko, E. V. Udut, O. Yu. Rybalkina, V. V. Zhdanov, V. V. Udut, A. M. Dygai & E. P. Zueva

  2. Laboratory of Physical Processes Modeling in Biology and Medicine, National Research Tomsk State University, Tomsk, Russia

    G. N. Zyuz’kov & V. V. Udut

Authors
  1. G. N. Zyuz’kov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. N. Amosova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. V. Chaikovskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. A. Miroshnichenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. V. Udut
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. Yu. Rybalkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. V. Zhdanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. V. Udut
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. M. Dygai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. P. Zueva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. N. Zyuz’kov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 161, No. 3, pp. 343-347, March, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zyuz’kov, G.N., Amosova, E.N., Chaikovskii, A.V. et al. Antitumor Effects of JAK3 Inhibitor on the Model of Transplantable Lewis Lung Carcinoma and Mechanisms of Their Development. Bull Exp Biol Med 161, 367–370 (2016). https://doi.org/10.1007/s10517-016-3415-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-016-3415-1

Key Words

Search

Navigation